Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mireia Pérez-Verdaguer, Jesusa Capera, Clara Serrano-Novillo, Irene Estadella, Daniel Sastre & Antonio Felipe. (2016) The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies. Expert Opinion on Therapeutic Targets 20:5, pages 577-591.
Read now
Read now
William Nguyen. (2013) Novel Kv1.3 blockers for immunosuppression: WO2012155199. Expert Opinion on Therapeutic Patents 23:11, pages 1511-1516.
Read now
Read now
Articles from other publishers (6)
Gilberto Pereira, Beatriz Szwarc, Miguel A. Mondragão, Pedro A. Lima & Florbela Pereira. (2018)
A Ligand-Based Approach to the Discovery of Lead-Like Potassium Channel K
V
1.3 Inhibitors
. ChemistrySelect 3:5, pages 1352-1364.
Crossref
Crossref
Anantha Maharasi RamaKrishnan & Kavitha Sankaranarayanan. (2016) Understanding autoimmunity: The ion channel perspective. Autoimmunity Reviews 15:7, pages 585-620.
Crossref
Crossref
Manuela B. Pucca, Thaís B. Bertolini, Felipe A. Cerni, Karla C. F. Bordon, Steve Peigneur, Jan Tytgat, Vânia L. Bonato & Eliane C. Arantes. (2016)
Immunosuppressive evidence of
Tityus serrulatus
toxins Ts6 and Ts15: insights of a novel K
+
channel pattern in T cells
. Immunology 147:2, pages 240-250.
Crossref
Crossref
Chuan Tian, Ruixin Zhu, Lixin Zhu, Tianyi Qiu, Zhiwei Cao & Tingguo Kang. (2014) Potassium Channels: Structures, Diseases, and Modulators. Chemical Biology & Drug Design 83:1, pages 1-26.
Crossref
Crossref
Tadashi Katoh. 2014.
1
39
.
Kseniya S. Kudryashova, Oksana V. Nekrasova, Alexey I. Kuzmenkov, Alexander A. Vassilevski, Anastasia A. Ignatova, Yuliya V. Korolkova, Eugene V. Grishin, Mikhail P. Kirpichnikov & Alexey V. Feofanov. (2013) Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study. Analytical and Bioanalytical Chemistry 405:7, pages 2379-2389.
Crossref
Crossref